Topic in Focus: Naloxone

AMA Ed Hub Logo
Learn more on Naloxone from AMA Ed Hub™.
Red JAMA Logo
Learn more on Naloxone from JAMA Network™.
Illustration of three physicians
6 reasons to join the AMA
Clear Search
·
2 MIN READ

AMA statement on making naloxone available over the counter

The AMA strongly supports the FDA decision to make the opioid overdose-reversing drug naloxone available over the counter, a position we have long championed.

Press Releases
Arrow travelling down
·
10 MIN READ

What doctors wish patients knew about falling U.S. life expectancy

The last time the U.S. experienced a two-year decline in life expectancy was during World War II. Three physicians share more about life expectancy.

series
Public Health
What Doctors Wish Patients Knew™
·
4 MIN READ

AMA in the News: February 2023

Read media highlights mentioning the American Medical Association for February 2023.

series
AMA in the News
AMA in the News
·
13 MIN READ

Feb. 24, 2023: National Advocacy Update

FDA advisory panels vote 19-0 in favor of OTC naloxone and more in the latest National Advocacy Update.

Advocacy Update
·
2 MIN READ

AMA: FDA panels’ naloxone recommendation will save lives

Two advisory committees voted today to recommend to the FDA that naloxone, the overdose-reversing drug, be available over the counter.

Press Releases
UPDATED
·
5 MIN READ

Working with health care delivery systems in novel ways

See how consortium schools are partnering with health care systems to bring students out of classrooms so they can learn in authentic health care settings.

ChangeMedEd Initiative
Profile of smiling person looking out the window
·
4 MIN READ

Meet 25 heroes saving lives amid the drug-overdose epidemic

It’s time to pursue policies shown to help. An AMA report celebrates the physicians and advocates working to follow the evidence.

Overdose Epidemic
·
1 MIN READ

AMA statement on CDC mortality numbers

Decreased life expectancy provides a sobering reminder that our nation must embrace an evidence-driven, public health approach to confront health care issues.

Press Releases
Delegates stand in line to speak at the 2022 Interim Meeting
·
3 MIN READ

Harm-reduction efforts needed to curb overdose epidemic

AMA backs greater use of point-of-care fentanyl test strips and using opioid-litigation settlement funds to boost physician training. Learn more.

Overdose Epidemic